Italian pharmaceutical group Recordati said on Tuesday it confirmed its 2022 financial targets despite the ongoing conflict in Ukraine, after posting a rise in sales and core earnings in the first ...
July 30 (Reuters) - Italian drug maker Recordati (RECI.MI), opens new tab raised its guidance for 2024 on Tuesday buoyed by positive momentum in its mainline Specialty and Primary Care and Rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback